AN2 Therapeutics
ANTX
ANTX
54 hedge funds and large institutions have $60.9M invested in AN2 Therapeutics in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 12 increasing their positions, 17 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
85% less capital invested
Capital invested by funds: $418M → $60.9M (-$357M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
54
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.42M | |
| 2 | +$713K | |
| 3 | +$529K | |
| 4 |
Walleye Capital
New York
|
+$432K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$336K |
Top Sellers
| 1 | -$3.84M | |
| 2 | -$3.65M | |
| 3 | -$3.24M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$2.7M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.91M |